---
figid: PMC3280691__nihms355182f1
figtitle: 'Beta-catenin signaling: a novel mediator of fibrosis and potential therapeutic
  target'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Lareunionomyces loeiensis
- Mouse mammary tumor virus
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Danio rerio
pmcid: PMC3280691
filename: nihms355182f1.jpg
figlink: /pmc/articles/PMC3280691/figure/F1/
number: F1
caption: In the absence of Wnt (left), cytosolic β-catenin is continually phosphorylated
  by casein kinase 1α (CK1α) and glycogen synthase kinase 3β (GSK-3β) within an Axin1
  scaffold complex. This phosphorylation allows β-catenin to be recognized by a specific
  E3 ligase (βTrCP, not shown), which catalyzes the ubiquitylation and rapid degradation
  of β-catenin. The adenomatous polyposis coli (APC) tumor suppressor participates
  in the phosphodestruction of β-catenin by antagonizing β-catenin dephosphorylation
  by phosphatases. During Wnt activation (right), GSK3β activity is inhibited directly
  by LDL receptor related protein 5 and 6 (LRP5/6), which allows β-catenin to accumulate,
  enter the nucleus, interact with LEF/TCF family members and activate target genes.
  Fibrosis-relevant targets of Wnt/β-catenin signaling remain to be clarified. General
  targets of Wnt/β-catenin signaling include negative feedback regulators, Axin2,
  Naked (NKD) and Dickkopf (DKK).
papertitle: 'β-catenin signaling: a novel mediator of fibrosis and potential therapeutic
  target.'
reftext: Anna P. Lam, et al. Curr Opin Rheumatol. ;23(6):562-567.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9235762
figid_alias: PMC3280691__F1
figtype: Figure
redirect_from: /figures/PMC3280691__F1
ndex: fa51e378-de97-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3280691__nihms355182f1.html
  '@type': Dataset
  description: In the absence of Wnt (left), cytosolic β-catenin is continually phosphorylated
    by casein kinase 1α (CK1α) and glycogen synthase kinase 3β (GSK-3β) within an
    Axin1 scaffold complex. This phosphorylation allows β-catenin to be recognized
    by a specific E3 ligase (βTrCP, not shown), which catalyzes the ubiquitylation
    and rapid degradation of β-catenin. The adenomatous polyposis coli (APC) tumor
    suppressor participates in the phosphodestruction of β-catenin by antagonizing
    β-catenin dephosphorylation by phosphatases. During Wnt activation (right), GSK3β
    activity is inhibited directly by LDL receptor related protein 5 and 6 (LRP5/6),
    which allows β-catenin to accumulate, enter the nucleus, interact with LEF/TCF
    family members and activate target genes. Fibrosis-relevant targets of Wnt/β-catenin
    signaling remain to be clarified. General targets of Wnt/β-catenin signaling include
    negative feedback regulators, Axin2, Naked (NKD) and Dickkopf (DKK).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - wh
  - Lrp6
  - Lrp5
  - Axin2
  - Axin1
  - Gsk3b
  - Apc
  - Ctnnb1
  - Nkd1
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - LRP6
  - LRP5
  - KRT10
  - AXIN2
  - AXIN1
  - GSK3A
  - GSK3B
  - APC
  - PROC
  - CTNNB1
  - HNF4A
  - NKD1
  - NKD2
  - lrp6
  - lrp5
  - axin2
  - axin1
  - gsk3ba
  - gsk3ab
  - apc
  - ctnnb1
  - elk4
---
